Search Results 7751-7760 of 35809 for oral

  1. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    Participation eligibility · Ability to swallow and retain oral tablets. · Women of childbearing potential and men must agree to use adequate contraception ( ...

  2. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    If female and of childbearing potential, or if male, agree to use adequate contraception (e.g., abstinence, intrauterine device, oral contraceptive, or ...

  3. Orthopedic Surgery - Clinical trials

    The purpose of this study is to evaluate the impact of an extended oral TXA regimen on patient reported outcome scores, time to independent ambulation, ...

  4. VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303) - Mayo Clinic

    * Anticipated administration of oral or parenteral antibacterial therapy for a non-CDI indication after randomization. Note: Other protocol defined Inclusion ...

  5. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    * Participant has demonstrated intolerance or inadequate response to one or more of the following categories of drugs: aminosalicylates, oral locally acting ...

  6. Pathologists' Assistant Clinical Rotation (Florida) - Health Sciences Education

    Excellent written and oral communication skills. Non-U.S. citizen applicants. Admission to Mayo Clinic School of Health Sciences is open to U.S. workers in ...

  7. S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer - Mayo Clinic

    Gastrointestinal (GI) disease or GI procedure that could interfere with the GI absorption or tolerance of TAK-700, including difficulty swallowing oral ...

  8. Dermatology - Doctors - Mayo Clinic

    edema, Stevens-Johnson syndrome, Dermatitis, Oral lichen planus, Contact dermatitis, Erythromelalgia. Show more areas of focus for Mark Denis P. Davis, M.D. ...

  9. A Study to Evaluate ALZT-OP1a in Subjects with Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

    Inability to tolerate the administration of an oral inhaled powder via dry powder inhaler (DPI). Has taken any investigational study drug within 30 days or ...

  10. Study of RP-3500 With Niraparib or Olaparib in Advanced Solid Tumors - Mayo Clinic

    - Ability to swallow and retain oral medications. Exclusion Criteria: - Prior therapy with an ATR or DNA-dependent protein kinase (DNA-PK) inhibitor ...